CCM
Camber Capital Management Portfolio holdings
AUM
$718M
This Quarter Return
+4.1%
1 Year Return
-4.23%
3 Year Return
+26.63%
5 Year Return
+47.71%
10 Year Return
+121.3%
AUM
$1.76B
AUM Growth
+$1.76B
(-18%)
Cap. Flow
-$460M
Cap. Flow
% of AUM
-26.22%
Top 10 Holdings %
Top 10 Hldgs %
65.56%
Holding
36
New
3
Increased
6
Reduced
9
Closed
8
Top Buys
| 1 |
McKesson
MCK
|
$99.5M |
| 2 |
Viatris
VTRS
|
$45.8M |
| 3 |
TSRO
TESARO, Inc.
TSRO
|
$39M |
| 4 |
Puma Biotechnology
PBYI
|
$34.4M |
| 5 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$22M |
Top Sells
| 1 |
GHDX
Genomic Health, Inc.
GHDX
|
$124M |
| 2 |
SHPG
Shire pic
SHPG
|
$110M |
| 3 |
NUVA
NuVasive, Inc.
NUVA
|
$62.5M |
| 4 |
Myriad Genetics
MYGN
|
$56.1M |
| 5 |
CSII
Cardiovascular Systems, Inc.
CSII
|
$53.3M |
Sector Composition
| 1 | Healthcare | 92.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AGN
1
DELISTED
Allergan plc
AGN
| $171M | 7.34% | 900,000 -105,000 | -10% | -$20M |
|
2
HCA Healthcare
HCA
$94.5B
| $139M | 5.95% | 1,000,000 -350,000 | -26% | -$48.7M |
|
|
3
Viatris
VTRS
$12.3B
| $137M | 5.87% | 3,750,000 +1,250,000 | +50% | +$45.8M |
|
|
TSRO
4
DELISTED
TESARO, Inc.
TSRO
| $137M | 5.84% | 3,500,000 +1,000,000 | +40% | +$39M |
|
5
Universal Health Services
UHS
$11.6B
| $115M | 4.92% | 900,000 | – | – |
|
6
Biogen
BIIB
$19.4B
| $106M | 4.54% | 300,000 -150,000 | -33% | -$53M |
|
|
7
McKesson
MCK
$85.4B
| $99.5M | 4.26% | +750,000 | New | +$99.5M |
|
8
Nektar Therapeutics
NKTR
$568M
| $91.4M | 3.91% | 1,500,000 -500,000 | -25% | -$30.5M |
|
|
GBT
9
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $78.9M | 3.37% | 2,075,000 -125,000 | -6% | -$4.75M |
|
|
MNTA
10
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $75.7M | 3.24% | 2,878,890 -176,110 | -6% | -$4.63M |
|
11
Perrigo
PRGO
$3.27B
| $70.8M | 3.03% | 1,000,000 +75,000 | +8% | +$5.31M |
|
12
Atara Biotherapeutics
ATRA
$84.6M
| $67M | 2.87% | 1,620,000 | – | – |
|
13
Brookdale Senior Living
BKD
$1.83B
| $63.9M | 2.73% | 6,500,000 | – | – |
|
|
EVHC
14
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $62M | 2.65% | 1,355,000 -295,000 | -18% | -$13.5M |
|
|
MDCO
15
DELISTED
Medicines Co
MDCO
| $59.8M | 2.56% | 2,000,000 | – | – |
|
|
AMAG
16
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $53M | 2.27% | 2,650,000 | – | – |
|
|
CLVS
17
DELISTED
Clovis Oncology, Inc.
CLVS
| $51.4M | 2.2% | 1,750,000 +750,000 | +75% | +$22M |
|
18
Tenet Healthcare
THC
$16.3B
| $44.1M | 1.89% | 1,550,000 -700,000 | -31% | -$19.9M |
|
|
19
Puma Biotechnology
PBYI
$254M
| $34.4M | 1.47% | +750,000 | New | +$34.4M |
|
|
KTWO
20
DELISTED
K2M Group Holdings, Inc
KTWO
| $27.4M | 1.17% | 1,000,000 -1,000,000 | -50% | -$27.4M |
|
21
Zymeworks
ZYME
$1.12B
| $21.6M | 0.92% | 1,373,000 +123,000 | +10% | +$1.93M |
|
|
EGRX
22
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $20.2M | 0.87% | 291,600 +30,500 | +12% | +$2.11M |
|
|
ELGX
23
DELISTED
Endologix Inc
ELGX
| $17.8M | 0.76% | 9,300,000 | – | – |
|
24
Sutro Biopharma
STRO
$72.7M
| $9M | 0.39% | +600,000 | New | +$9M |
|
25
Surgery Partners
SGRY
$2.91B
| $2.23M | 0.1% | 135,084 | – | – |
|